Business
Currency:EUR
2024/Q2
Stock NameRevenueRatio
Discovery and development of innovative, RNA based therapeutics6.31M100.00%
Region
Currency:EUR
2023/FY
Stock NameRevenueRatio
United States6.51M100.00%